ArticleHuman reproduction open2025

Two-year follow-up study (PRIMROSE 3) to assess bone mineral density in subjects with uterine fibroids completing the PRIMROSE 1 and PRIMROSE 2 linzagolix trials.

Jacques Donnez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.